Navigation Links
aTyr Pharma Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology
Date:6/17/2011

SAN DIEGO, June 17, 2011 /PRNewswire/ -- aTyr Pharma, an innovative protein therapeutics company, announced today that Red Herring has named the company as a winner of the 2011 Red Herring 100 North America Award, a prestigious list honoring the year's most promising private companies. aTyr was recognized for its leadership and innovation in the discovery of Physiocrines and development of Physiocrine-based medicines. Physiocrines are naturally occurring human proteins that possess novel in vivo biological activity as extracellular signaling molecules in known pathways relevant to developing protein therapeutics for a range of diseases.

Dr. John Mendlein, executive chairman of aTyr Pharma, said, "Physiocrine protein pathways represent important new therapeutic intervention points for drug discovery.  aTyr is uncovering the role of Physiocrines from an ancient gene family in modulating human physiology and intervening in disease to develop life-changing medicines for patients with grave conditions."

Physiocrines are a recently elucidated class of endogenous human proteins from amino acyl tRNA synthetases that function as extracellular signaling molecules in a variety of physiologic settings.   As either therapeutic proteins or as targets for antibodies, Physiocrines have the potential to address a wide range of diseases, including high unmet patient needs in blood, immune, and metabolism disorders.

"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across North America to the Top 100 Winners. We believe aTyr Pharma embodies the vision, drive and innovation that define a successful entrepreneurial venture." 

Red Herring 100 North America list has become a mark of distinction for identifying promising new companies and entrepreneurs. The Red Herring 100 winners are evaluated on both quantitative and qualitative criteria, such as technology innovation, quality of management and execution of strategy into their respective industries. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Skype, YouTube and eBay would change the way we live and work.

"This award recognizes that the development of Physiocrine-based protein therapeutics is distinct from current protein therapeutic programs," said Dr. Jeff Watkins, CEO of aTyr Pharma. "aTyr possesses a unique opportunity to advance new therapeutic applications from novel mechanisms for the development of innovative, high-impact biologics."

About aTyr Pharma

aTyr Pharma develops biologic therapeutics based on Physiocrines and amino acyl tRNA synthetases and is currently focusing on developing products for hematologic and immune indications. aTyr has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. The company's lead program, Tmax, is in preclinical development. The privately held biotech was founded by Scripps Research Institute Professor Paul Schimmel, a leading amino acyl tRNA synthetase scientist, and is backed by leading life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures. For more information, please visit http://www.atyrpharma.com.


'/>"/>
SOURCE aTyr Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
2. Florida Independent Drugstores Attack Mail-Service Pharmacies, Put Profits Ahead of Patients
3. Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
4. Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes
5. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
6. Ampio Pharmaceuticals Set to Join Russell 3000 Index
7. PDL BioPharma Completes Regular Quarterly Dividend Payment
8. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
9. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
10. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
11. Saint-Gobains New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- Indiso ltd , a medical technology company ... respiratory diseases announced today positive results in its clinical ... patients show improvements in respiratory functions and other clinical ... Upper and lower respiratory tract diseases and allergy ... reached epidemic level. Increasing number of studies however show ...
(Date:2/10/2016)... http://www.researchandmarkets.com/research/rp4pg8/molecular ) has ... Diagnostics Reports Bundle" report to their ... announced the addition of the "Molecular ... offering. --> Research and Markets ... of the "Molecular Diagnostics Reports Bundle" ...
(Date:2/10/2016)...  Cepheid (Nasdaq: CPHD ) today announced ... President and Chief Operating Officer, has been promoted ... Officer.  In his new capacity, Mr. Kocmond,s responsibilities ... Operations in addition to Manufacturing Operations, Engineering, Technical ... to report to John Bishop , Cepheid,s ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Colorado spine surgeon, ... of 334 spine surgeons to know in 2016 . The list consists of ... of spine surgery. , Dr. Corenman understands the importance of clinical excellence; he ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment ... in support of a local boy named Barrett, who has been fighting ALL leukemia ... and rally support for, all local families dealing with childhood cancer. Information on how ...
(Date:2/11/2016)... ... February 11, 2016 , ... From March ... Academy of Dermatology Annual Meeting at the Walter E. Washington Convention Center in ... for both the condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, ...
(Date:2/11/2016)... ... ... The book, “Computers Should Just Work!”, provides a basic, non-techie education on how ... signing a contract and how to spot an incompetent or dishonest IT person before ... and technology, it’s more important than ever to make sure the company you outsource ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th ... Molecular Imaging Congress (WMIC), will be held in New York City, NY on ... Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a greater ...
Breaking Medicine News(10 mins):